4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-057117
Director sold 755 shares at $49.89 ($37,667)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Salter Malcolm Director | 2021-09-17 | Sale | −755 | $49.89 | $37,667 | 12,917 | D |
| Open-market sales · 755 sh · avg $49.89 · $37,667 | |||||||
Loading xslF345X03/doc4.xml…